Care pathway heterogeneity in Amyotrophic Lateral Sclerosis: effects of gender, age and onset
Neuroepidemiology · 2024
DOI: 10.1159/000542300 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroepidemiology, 2024. Verfasst von Marc Dibling und 4 weiteren Autor:innen. Beteiligte Einrichtung: ARAMIS, Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, CNRS, Inria, Inserm, AP-HP, Hôpital de la Pitie Salpêtrière, Paris, F…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Critical Pathways. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Background and objectives: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive motor neuron degeneration resulting in loss of muscle function. Care management is restricted to symptomatic and palliative strategies, while clinical manifestations are heterogeneous. However, assessing the timing and benefits of ALS major clinical interventions remains challenging, with varying and nonspecific time-to-events estimates reported in the literature. Consequently, we proposed a retrospective cohort study leveraging healthcare system data to investigate ALS patients care pathway stratified by gender, age class and onset site to describe strategies diversity and temporality.
Methods
We developed an algorithm to identify incident ALS patients in the French hospitalization registry and assessed its quality through comparison with literature. We described 7 states, encompassing patient status regarding clinical intervention history, considered 15 transitions and stratified the analysis depending on 12 different patient profiles, defined according to gender, the presence of symptoms indicative of disease onset site and age class, to model profile-specific care pathway trajectories. Alongside analysis of median time before transition, we compared acceleration factors resulting from Accelerated Failure Time (AFT) and time-inhomogeneous models.
Results
We identified 21,153 incident patients with ALS between 2013 and 2022 with a mean age of 67.7±13.1 years at time of in-registry detection, male/female and spinal/bulbar ratios of 1.2 and 1.9, respectively. Non-invasive ventilation (NIV), gastrostomy, tracheostomy or death at hospital was recorded for 55.24% of the study population. We identified significant variations in utilization based on gender, age class, and onset site. Notably, older age and bulbar onset site accelerated gastrostomy use and spinal onset site was associated with delayed NIV initiation while tracheostomy, mainly considered for younger patients (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ARAMIS, Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, CNRS, Inria, Inserm, AP-HP, Hôpital de la Pitie Salpêtrière, Paris, France.
- Centre de Référence Maladies Rares SLA Ile de France, Département de Neurologie, GHU Pitié-Salpêtrière, Paris, France.
- ARAMIS, Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, CNRS, Inria, Inserm, AP-HP, Hôpital de la Pitie Salpêtrière, Paris, France, sophie.tezenas@aphp.fr.
Zitieren
APA
Dibling, M., Ortholand, J., Salachas, F., Hesters, A., & Tezenas du Montcel, S. (2024). Care pathway heterogeneity in Amyotrophic Lateral Sclerosis: effects of gender, age and onset. Neuroepidemiology. https://doi.org/10.1159/000542300
Vancouver
Dibling M, Ortholand J, Salachas F, Hesters A, Tezenas du Montcel S. Care pathway heterogeneity in Amyotrophic Lateral Sclerosis: effects of gender, age and onset. Neuroepidemiology. 2024. doi:10.1159/000542300
BibTeX
@article{Dibling2024,
author = {Dibling, Marc and Ortholand, Juliette and Salachas, François and Hesters, Adèle and Tezenas du Montcel, Sophie},
title = {Care pathway heterogeneity in Amyotrophic Lateral Sclerosis: effects of gender, age and onset},
journal = {Neuroepidemiology},
year = {2024},
doi = {10.1159/000542300}
}
EUVIMED